Literature DB >> 31032142

Confounders in Adenoma Detection at Initial Screening Colonoscopy: A Factor in the Assessment of Racial Disparities as a Risk for Colon Cancer.

Yakira David1,2, Lorenzo Ottaviano3, Jihye Park4, Sadat Iqbal1, Michelle Likhtshteyn1, Samir Kumar1, Helen Lyo1, Ayanna E Lewis3, Brandon E Lung3, Jesse T Frye3, Li Huang3, Ellen Li3, Jie Yang5, Laura Martello1, Shivakumar Vignesh1, Joshua D Miller3, Michele Follen6, Evan B Grossman1,7.   

Abstract

BACKGROUND AND AIMS: The incidence and mortality of colorectal cancer is persistently highest in Black/African-Americans in the United States. While access to care, barriers to screening, and poverty might explain these findings, there is increased interest in examining biological factors that impact the colonic environment. Our group is examining biologic factors that contribute to disparities in development of adenomas prospectively. In preparation for this and to characterize a potential patient population, we conducted a retrospective review of initial screening colonoscopies in a cohort of patients.
METHODS: A retrospective review was performed on initial average risk screening colonoscopies on patients (age 45-75 years) during 2012 at three institutions. Descriptive statistics and multivariable logistic regression models were used to examine the relationship between potential risk factors and the detection of adenomas.
RESULTS: Of the 2225 initial screening colonoscopies 1495 (67.2%) were performed on Black/African-Americans and 566 (25.4%) on Caucasians. Multivariable logistic regression revealed that older age, male sex, current smoking and teaching gastroenterologists were associated with higher detection of adenomas and these were less prevalent among Black/African-Americas except for age. Neither race, ethnicity, BMI, diabetes mellitus, HIV nor insurance were associated with adenoma detection.
CONCLUSION: In this sample, there was no association between race and adenoma detection. While this may be due to a lower prevalence of risk factors for adenomas in this sample, our findings were confounded by a lower detection rate by consultant gastroenterologists at one institution. The study allowed us to rectify the problem and characterize patients for future trials.

Entities:  

Keywords:  Adenoma; Cancer; Colorectal; Quality; Screening

Year:  2019        PMID: 31032142      PMCID: PMC6482964          DOI: 10.4236/jct.2019.104022

Source DB:  PubMed          Journal:  J Cancer Ther        ISSN: 2151-1934


  51 in total

1.  Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; John H Bond; Sidney Winawer; Theodore R Levin; Randall W Burt; David A Johnson; Lynne M Kirk; Scott Litlin; David A Lieberman; Jerome D Waye; James Church; John B Marshall; Robert H Riddell
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

2.  Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention.

Authors:  Jean-Pierre Reinhold; Marianne Moon; Craig T Tenner; Michael A Poles; Edmund J Bini
Journal:  Am J Gastroenterol       Date:  2005-08       Impact factor: 10.864

3.  Screening colonoscopy in asymptomatic average-risk African Americans.

Authors:  D K Rex; A M Khan; P Shah; J Newton; O W Cummings
Journal:  Gastrointest Endosc       Date:  2000-05       Impact factor: 9.427

4.  Why do African Americans get more colon cancer than Native Africans?

Authors:  Stephen J D O'Keefe; Dan Chung; Nevine Mahmoud; Antonia R Sepulveda; Mashudu Manafe; Judith Arch; Haytham Adada; Tian van der Merwe
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

5.  Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older.

Authors:  Edmund J Bini; James Park; Fritz Francois
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

6.  Colorectal cancer in a multi-ethnic urban group: its anatomical and age profile.

Authors:  D Chattar-Cora; G D Onime; I S Valentine; E Cudjoe; L Rivera
Journal:  Int Surg       Date:  2000 Apr-Jun

7.  Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients.

Authors:  David A Lieberman; Jennifer L Holub; Matthew D Moravec; Glenn M Eisen; Dawn Peters; Cynthia D Morris
Journal:  JAMA       Date:  2008-09-24       Impact factor: 56.272

8.  Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.

Authors:  Ann C DeBourcy; Scott Lichtenberger; Susanne Felton; Kiel T Butterfield; Dennis J Ahnen; Thomas D Denberg
Journal:  J Gen Intern Med       Date:  2007-12-21       Impact factor: 5.128

9.  Influence of demographics on colorectal cancer.

Authors:  Gamal Mostafa; Brent D Matthews; H James Norton; Kent W Kercher; Ronald F Sing; B Todd Heniford
Journal:  Am Surg       Date:  2004-03       Impact factor: 0.688

10.  Racial variation in colorectal polyp and tumor location.

Authors:  Julia Gore Thornton; Arden M Morris; John Daryl Thornton; Christopher R Flowers; Timothy M McCashland
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

View more
  3 in total

Review 1.  Analysing the nanoparticle-protein corona for potential molecular target identification.

Authors:  Chandra Kumar Elechalawar; Md Nazir Hossen; Lacey McNally; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  J Control Release       Date:  2020-03-09       Impact factor: 9.776

2.  Symptomatic Colorectal Cancer Is Associated With Stage IV Diagnosis in Two Disparate Populations.

Authors:  Carmen Fong; Dimitri Joseph; Samuel Stanley; Yicong Zhu; Wei Zhu; Evan Grossman; Henry Talus; Maksim Agaronov; Alexandra Guillaume; Paula Denoya
Journal:  Cureus       Date:  2022-09-02

Review 3.  Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.

Authors:  Carolyn M Rutter; Amy B Knudsen; Jennifer S Lin; Kathryn E Bouskill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-03       Impact factor: 4.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.